In vitro anticancer activity of hydrogen sulfide and nitric oxide alongside nickel nanoparticle and novel mutations in their genes in CRC patients

Sci Rep. 2021 Jan 28;11(1):2536. doi: 10.1038/s41598-021-82244-x.

Abstract

This study was carried out to assess the impact of nickel nanoparticles (NiNPs) as well as scorpion venom on colorectal cancer (CRC) cells in the presence and/or absence of 5-fluorouracil (5-FU), hydrogen sulfide (H2S), and nitric oxide (NO) donors and to determine alterations in endothelial NO synthase (eNOS) and cystathionine γ-lyase (CSE) enzyme-producing genes in CRC patients. The IC50 of both H2S and NO donors, along with NiNPs, were determined. The CRC cells were treated for 24hrs, and the cytotoxic activities were assessed using the MTT test. Moreover, the apoptosis was determined after 24hrs and 48hrs using TUNEL assay. Furthermore, the mutations in the eNOS gene (intron 4, -786T>C and 894 G>T) and CSE gene (1364GT) were determined using direct sequencing. The IC50 values for sodium disulfide (Na2S) and sodium nitroprusside (SNP) at 24hrs treatment were found to be 5 mM and 10-6 M, respectively, while the IC50 value for 5-FU was reached after 5-days of treatment in CRC cell line. Both black and yellow scorpion venoms showed no inhibition of cell proliferation after 24hrs treatment. Furthermore, Na2S showed a significant decrease in cell proliferation and an increase in apoptosis. Moreover, a co-treatment of SNP and 5-FU resulted in inhibition of the cytotoxic effect of 5-FU, while a combination treatment of NiNPs with Na2S, SNP, and 5-FU caused highly significant cytotoxicity. Direct sequencing reveals new mutations, mainly intronic variation in eNOS gene that has not previously been described in the database. These findings indicate that H2S promotes the anticancer efficiency of 5-FU in the presence of NiNPs while NO has antiapoptotic activity in CRC cell lines.

MeSH terms

  • Alleles
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Survival
  • Colorectal Neoplasms
  • DNA Mutational Analysis
  • Fluorouracil / pharmacology
  • Genotype
  • Humans
  • Hydrogen Sulfide / administration & dosage
  • Hydrogen Sulfide / chemistry
  • Hydrogen Sulfide / pharmacology*
  • Metal Nanoparticles*
  • Mutation*
  • Nickel*
  • Nitric Oxide / administration & dosage
  • Nitric Oxide / chemistry
  • Nitric Oxide / pharmacology*
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / metabolism
  • Nitroprusside / pharmacology
  • Polymorphism, Single Nucleotide
  • Scorpion Venoms / administration & dosage
  • Scorpion Venoms / pharmacology

Substances

  • Antineoplastic Agents
  • Scorpion Venoms
  • Nitroprusside
  • Nitric Oxide
  • Nickel
  • Nitric Oxide Synthase Type III
  • Fluorouracil
  • Hydrogen Sulfide